1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dengue Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by Application
1.5.1 Global Dengue Vaccine Market Share by Application: 2021-2026
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Dengue Vaccine Market
1.8.1 Global Dengue Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Dengue Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Dengue Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Dengue Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Dengue Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Dengue Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Dengue Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Dengue Vaccine Sales Volume
3.3.1 North America Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Dengue Vaccine Sales Volume
3.4.1 East Asia Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Dengue Vaccine Sales Volume (2015-2020)
3.5.1 Europe Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Dengue Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Dengue Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Dengue Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Dengue Vaccine Sales Volume (2015-2020)
3.9.1 Africa Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Dengue Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Dengue Vaccine Sales Volume (2015-2020)
3.11.1 South America Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Dengue Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Dengue Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Dengue Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Dengue Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Dengue Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Dengue Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Dengue Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Dengue Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Dengue Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Dengue Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Dengue Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Dengue Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Dengue Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Dengue Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Dengue Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Dengue Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Dengue Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Dengue Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Dengue Vaccine Business
16.1 GlaxoSmithKline
16.1.1 GlaxoSmithKline Company Profile
16.1.2 GlaxoSmithKline Dengue Vaccine Product Specification
16.1.3 GlaxoSmithKline Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Sun Pharmaceutical
16.2.1 Sun Pharmaceutical Company Profile
16.2.2 Sun Pharmaceutical Dengue Vaccine Product Specification
16.2.3 Sun Pharmaceutical Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Takeda Pharmaceuticals
16.3.1 Takeda Pharmaceuticals Company Profile
16.3.2 Takeda Pharmaceuticals Dengue Vaccine Product Specification
16.3.3 Takeda Pharmaceuticals Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Merck Sharp & Dohme
16.4.1 Merck Sharp & Dohme Company Profile
16.4.2 Merck Sharp & Dohme Dengue Vaccine Product Specification
16.4.3 Merck Sharp & Dohme Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Panacea Biotec
16.5.1 Panacea Biotec Company Profile
16.5.2 Panacea Biotec Dengue Vaccine Product Specification
16.5.3 Panacea Biotec Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Sanofi
16.6.1 Sanofi Company Profile
16.6.2 Sanofi Dengue Vaccine Product Specification
16.6.3 Sanofi Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Vabiotec
16.7.1 Vabiotec Company Profile
16.7.2 Vabiotec Dengue Vaccine Product Specification
16.7.3 Vabiotec Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Medigen Biologics
16.8.1 Medigen Biologics Company Profile
16.8.2 Medigen Biologics Dengue Vaccine Product Specification
16.8.3 Medigen Biologics Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 GeneOne Life Sciences
16.9.1 GeneOne Life Sciences Company Profile
16.9.2 GeneOne Life Sciences Dengue Vaccine Product Specification
16.9.3 GeneOne Life Sciences Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 U.S NIH
16.10.1 U.S NIH Company Profile
16.10.2 U.S NIH Dengue Vaccine Product Specification
16.10.3 U.S NIH Dengue Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Dengue Vaccine Manufacturing Cost Analysis
17.1 Dengue Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Dengue Vaccine
17.4 Dengue Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Dengue Vaccine Distributors List
18.3 Dengue Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Dengue Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Dengue Vaccine (2021-2026)
20.3 Global Forecasted Price of Dengue Vaccine (2015-2026)
20.4 Global Forecasted Production of Dengue Vaccine by Region (2021-2026)
20.4.1 North America Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Dengue Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Dengue Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Dengue Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Dengue Vaccine by Country
21.3 Europe Market Forecasted Consumption of Dengue Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Dengue Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Dengue Vaccine by Country
21.6 Middle East Forecasted Consumption of Dengue Vaccine by Country
21.7 Africa Forecasted Consumption of Dengue Vaccine by Country
21.8 Oceania Forecasted Consumption of Dengue Vaccine by Country
21.9 South America Forecasted Consumption of Dengue Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Dengue Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer